FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ken Bulpitt

Research Profile

Disorders

Rheumatoid Arthritis

Chemicals & Drugs

Concepts & Ideas

Anatomy

Activities & Behaviors

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Katherine L Kahn; Catherine H MacLean; Honghu Liu; Laurence Z Rubenstein; Andrew L Wong; Judith O Harker; Wen-Pin Chen; Diane M Fitzpatrick; Ken J Bulpitt; Shana B Traina; Brian S Mittman; Bevra H Hahn; Harold E Paulus
The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care.
Katherine L Kahn; Catherine H MacLean; Honghu Liu; Laurence Z Rubenstein; Andrew L Wong; Judith O Harker; Wen-Pin Chen; Diane M Fitzpatrick; Ken J Bulpitt; Shana B Traina; Brian S Mittman; Bevra H Hahn; Harold E Paulus
Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.
Sogol Amjadi; Sogol Amjadi-Begvand; Dinesh Khanna; Grace S Park; Ken J Bulpitt; Weng Kee Wong; Harold E Paulus
Dating the "window of therapeutic opportunity" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ken Bulpitt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Katherine L Kahn; Catherine H MacLean; Honghu Liu; Laurence Z Rubenstein; Andrew L Wong; Judith O Harker; Wen-Pin Chen; Diane M Fitzpatrick; Ken J Bulpitt; Shana B Traina; Brian S Mittman; Bevra H Hahn; Harold E Paulus
The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care.
Medical care 2007;45(1):55-65.
2006: Katherine L Kahn; Catherine H MacLean; Honghu Liu; Laurence Z Rubenstein; Andrew L Wong; Judith O Harker; Wen-Pin Chen; Diane M Fitzpatrick; Ken J Bulpitt; Shana B Traina; Brian S Mittman; Bevra H Hahn; Harold E Paulus
Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.
Arthritis and rheumatism 2006;55(6):884-91.
2004: Sogol Amjadi; Sogol Amjadi-Begvand; Dinesh Khanna; Grace S Park; Ken J Bulpitt; Weng Kee Wong; Harold E Paulus
Dating the "window of therapeutic opportunity" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset.
The Journal of rheumatology 2004;31(9):1686-92.
2004: Andrew L Wong; Judith O Harker; Brian S Mittman; Gerald D Levy; Ken J Bulpitt; Keith K Colburn; Honghu Liu; Katherine L Kahn; Bevra H Hahn; Harold E Paulus; Laurence Z Rubenstein
Development and evaluation of a patient self-report case-finding method for rheumatoid arthritis.
Seminars in arthritis and rheumatism 2004;34(1):484-99.
2004: Honghu Liu; Judith O Harker; Andrew L Wong; Catherine H MacLean; Ken J Bulpitt; Brian S Mittman; John FitzGerald; Jennifer Grossman; Laurence Z Rubenstein; Bevra Hahn; Harold E Paulus; Katherine L Kahn
Case finding for population-based studies of rheumatoid arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for diagnosis of rheumatoid arthritis.
Seminars in arthritis and rheumatism 2004;33(5):302-10.
2004: Harold E Paulus; MyungShin Oh; John T Sharp; Richard H Gold; Weng Kee Wong; Grace S Park; Ken J Bulpitt
Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
Arthritis and rheumatism 2004;50(4):1083-96.
2003: Daniel E Furst; Michael Weisman; Harold E Paulus; Ken J Bulpitt; Michael E Weinblatt; Richard Polisson; Michel Zaug; Johannes Kneer; Philippe Van der Auwera; Randall M Stevens
Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.
The Journal of rheumatology 2003;30(10):2123-6.
2003: Joel M Kremer; Michael E Weinblatt; Arthur D Bankhurst; Ken J Bulpitt; Roy Fleischmann; Christopher G Jackson; Kelly M Atkins; Anyang Feng; Daniel J Burge
Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Arthritis and rheumatism 2003;48(6):1493-9.
2003: Harold E Paulus; MyungShin Oh; John T Sharp; Richard H Gold; Weng Kee Wong; Grace S Park; Ken J Bulpitt
Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis.
The Journal of rheumatology 2003;30(4):705-13.
2003: Arthur Kavanaugh; Mark Genovese; Jan Baughman; Alan J Kivitz; Ken J Bulpitt; Nancy Olsen; Michael Weisman; Eric Matteson; Daniel Furst; Ronald van Vollenhoven; James Anderson; Stanley Cohen; Nathan Wei; Jan Meijerink; Cindy Jacobs; Simonetta Mocci
Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.
The Journal of rheumatology 2003;30(3):449-54.
2002: Harold E Paulus; Jason Wiesner; Ken J Bulpitt; Madhumita Patnaik; Jacqueline Law; Grace S Park; Weng Kee Wong
Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
The Journal of rheumatology 2002;29(12):2513-20.
2001: Larry W Moreland; S B Cohen; Scott W Baumgartner; Elizabeth Tindall; Ken J Bulpitt; R Martin; Michael E Weinblatt; J Taborn; A Weaver; Daniel J Burge; Michael H Schiff
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.
The Journal of rheumatology 2001;28(6):1238-44.
2001: Bevra H Hahn; Ram Raj Singh; Weng Kee Wong; Betty P Tsao; Ken J Bulpitt; Fanny M Ebling
Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Arthritis and rheumatism 2001;44(2):432-41.
2000: Harold E Paulus; Ken J Bulpitt; B Ramos; Grace Park; Weng Kee Wong
Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.
Arthritis and rheumatism 2000;43(12):2743-50.
2000: K Newhall-Perry; NJ Law; B Ramos; Mildred G Sterz; Weng Kee Wong; Ken J Bulpitt; Grace Park; M Lee; Philip Clements; Harold E Paulus
Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
The Journal of rheumatology 2000;27(5):1156-63.
1999: Ken J Bulpitt
Biologic therapies in rheumatoid arthritis.
Current rheumatology reports 1999;1(2):157-63.
1999: A L Wong; Weng Kee Wong; Judith O Harker; Mildred G Sterz; Ken J Bulpitt; Grace Park; B Ramos; Philip Clements; Harold E Paulus
Patient self-report tender and swollen joint counts in early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
The Journal of rheumatology 1999;26(12):2551-61.
1999: Harold E Paulus; B Ramos; Weng Kee Wong; Alaa Ahmed; Ken J Bulpitt; Grace Park; Mildred G Sterz; Philip Clements
Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
The Journal of rheumatology 1999;26(11):2324-31.
1999: Larry W Moreland; Michael H Schiff; Scott W Baumgartner; Elizabeth Tindall; Roy Fleischmann; Ken J Bulpitt; Arthur L Weaver; Edward C Keystone; Daniel E Furst; P J Mease; Eric M Ruderman; David A Horwitz; Daniel G Arkfeld; L Garrison; Daniel J Burge; CM Blosch; M L Lange; N D McDonnell; Michael E Weinblatt
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
Annals of internal medicine 1999;130(6):478-86.
1999: Michael E Weinblatt; Joel M Kremer; Arthur D Bankhurst; Ken J Bulpitt; Roy Fleischmann; R I Fox; C G Jackson; M Lange; Daniel J Burge
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
The New England journal of medicine 1999;340(4):253-9.
1996: E Berkanovic; P Oster; W K Wong; Ken J Bulpitt; P Clements; Mildred G Sterz; H Paulus
The relationship between socioeconomic status and recently diagnosed rheumatoid arthritis.
Arthritis care and research : the official journal of the Arthritis Health Professions Association 1996;9(6):257-62.
1996: H E Paulus; D M van der Heijde; Ken J Bulpitt; R H Gold
Monitoring radiographic changes in early rheumatoid arthritis.
The Journal of rheumatology 1996;23(5):801-5.
1996: J D Isaacs; V K Manna; N Rapson; Ken J Bulpitt; B L Hazleman; Eric L Matteson; E William St Clair; T J Schnitzer; J M Johnston
CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study.
British journal of rheumatology 1996;35(3):231-40.
1995: Michael E Weinblatt; P J Maddison; Ken J Bulpitt; B L Hazleman; M B Urowitz; R D Sturrock; Jonathan S Coblyn; agnes lee maier; W R Spreen; V K Manna
CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study.
Arthritis and rheumatism 1995;38(11):1589-94.
1995: H E Paulus; Ken J Bulpitt
Rheumatoid arthritis. Outcome measures.
Rheumatic diseases clinics of North America 1995;21(3):605-18.
1994: H E Paulus; Ken J Bulpitt
DC-ART classification: review of relevant clinical studies.
The Journal of rheumatology. Supplement 1994;41():8-20; discussion 20-2.
1993: H E Paulus; Ken J Bulpitt
Clinical trials of osteoarthritis therapies.
British journal of rheumatology 1993;32(7):529-31.
1993: Ken J Bulpitt; P J Clements; P A Lachenbruch; H E Paulus; J B Peter; M S Agopian; J Z Singer; Virginia D Steen; Daniel O Clegg; CAROL ZIMINSKI; G S Alarcon; M E Luggen; R P Polisson; R F Willkens; James C Reading; H James Williams; J R Ward
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).
Annals of internal medicine 1993;118(8):602-9.
1991: M A Verity; Ken J Bulpitt; H E Paulus
Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients.
Human pathology 1991;22(1):3-11.
1990: Ken J Bulpitt; M A Verity; P J Clements; H E Paulus
Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia syndrome.
Arthritis and rheumatism 1990;33(7):918-29.
1989: E Macy; Ken J Bulpitt; R E Champlin; Andrew Saxon
Anaphylaxis to infusion of autologous bone marrow: an apparent reaction to self, mediated by IgE antibody to bovine serum albumin.
The Journal of allergy and clinical immunology 1989;83(5):871-5.
1989: Ken J Bulpitt; Ernest Brahn
Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: diagnosis by antemortem skin biopsy.
The Journal of rheumatology 1989;16(5):677-80.